Replimune Group Inc buy BMO Capital Markets
Start price
22.01.25
/
50%
€12.90
Target price
22.01.26
€25.92
Performance (%)
-51.94%
Price
16.01.26
€6.20
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets for Replimune Group Inc is performing very badly with a performance of -51.94%. This prediction currently runs until 22.01.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Replimune Group Inc | -10.145% | -10.145% |
| iShares Core DAX® | 0.191% | 4.892% |
| iShares Nasdaq 100 | -0.614% | 2.901% |
| iShares Nikkei 225® | 0.599% | 7.404% |
| iShares S&P 500 | -0.036% | 3.489% |
Comments by BMO_Capital_Markets for this prediction
In the thread Replimune Group Inc diskutieren
Replimune Group, Inc. (NASDAQ: REPL) had its price target raised by analysts at BMO Capital Markets from $18.00 to $27.00. They now have an "outperform" rating on the stock.
Ratings data for REPL provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Replimune Group Inc
Replimune Group Inc
Start price
Target price
Perf. (%)
€2.40
23.07.25
23.07.25
€1.70
23.07.26
23.07.26
152.08%
16.01.26
16.01.26
Replimune Group Inc
Start price
Target price
Perf. (%)
€15.40
22.11.24
22.11.24
€17.31
22.11.25
22.11.25
-49.03%
23.11.25
23.11.25